123 related articles for article (PubMed ID: 8557623)
1. Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor.
Nair SK; Elbaum D; Christianson DW
J Biol Chem; 1996 Jan; 271(2):1003-7. PubMed ID: 8557623
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of inhibitor affinity to variants of human carbonic anhydrase II.
Nair SK; Krebs JF; Christianson DW; Fierke CA
Biochemistry; 1995 Mar; 34(12):3981-9. PubMed ID: 7696263
[TBL] [Abstract][Full Text] [Related]
3. Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II.
Nair SK; Christianson DW
Biochemistry; 1993 May; 32(17):4506-14. PubMed ID: 8485129
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II.
Banerjee AL; Tobwala S; Ganguly B; Mallik S; Srivastava DK
Biochemistry; 2005 Mar; 44(10):3673-82. PubMed ID: 15751944
[TBL] [Abstract][Full Text] [Related]
6. Determinants of catalytic activity and stability of carbonic anhydrase II as revealed by random mutagenesis.
Krebs JF; Fierke CA
J Biol Chem; 1993 Jan; 268(2):948-54. PubMed ID: 8419374
[TBL] [Abstract][Full Text] [Related]
7. Structural influence of hydrophobic core residues on metal binding and specificity in carbonic anhydrase II.
Cox JD; Hunt JA; Compher KM; Fierke CA; Christianson DW
Biochemistry; 2000 Nov; 39(45):13687-94. PubMed ID: 11076507
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of inhibitor binding to human carbonic anhydrase II.
Boriack-Sjodin PA; Zeitlin S; Chen HH; Crenshaw L; Gross S; Dantanarayana A; Delgado P; May JA; Dean T; Christianson DW
Protein Sci; 1998 Dec; 7(12):2483-9. PubMed ID: 9865942
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: a new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies.
Chazalette C; Riviere-Baudet M; Scozzafava A; Abbate F; Ben Maarouf Z; Supuran CT
J Enzyme Inhib; 2001; 16(2):125-33. PubMed ID: 11342281
[TBL] [Abstract][Full Text] [Related]
10. Structure of His94-->Asp carbonic anhydrase II in a new crystalline form reveals a partially occupied zinc binding site.
Ippolito JA; Nair SK; Alexander RS; Kiefer LL; Fierke CA; Christianson DW
Protein Eng; 1995 Oct; 8(10):975-80. PubMed ID: 8771178
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
12. Selection of carbonic anhydrase variants displayed on phage. Aromatic residues in zinc binding site enhance metal affinity and equilibration kinetics.
Hunt JA; Fierke CA
J Biol Chem; 1997 Aug; 272(33):20364-72. PubMed ID: 9252341
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I.
Manokaran S; Banerjee J; Mallik S; Srivastava DK
Biochim Biophys Acta; 2010 Oct; 1804(10):1965-73. PubMed ID: 20620244
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of engineering the hydrophobic pocket of carbonic anhydrase II.
Fierke CA; Calderone TL; Krebs JF
Biochemistry; 1991 Nov; 30(46):11054-63. PubMed ID: 1657158
[TBL] [Abstract][Full Text] [Related]
15. Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants.
Boriack PA; Christianson DW; Kingery-Wood J; Whitesides GM
J Med Chem; 1995 Jun; 38(13):2286-91. PubMed ID: 7608893
[TBL] [Abstract][Full Text] [Related]
16. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.
Eriksson AE; Kylsten PM; Jones TA; Liljas A
Proteins; 1988; 4(4):283-93. PubMed ID: 3151020
[TBL] [Abstract][Full Text] [Related]
17. Crystallographic studies of azide binding to human carbonic anhydrase II.
Nair SK; Christianson DW
Eur J Biochem; 1993 Apr; 213(1):507-15. PubMed ID: 8477723
[TBL] [Abstract][Full Text] [Related]
18. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
19. Importance of the conserved active-site residues Tyr7, Glu106 and Thr199 for the catalytic function of human carbonic anhydrase II.
Liang Z; Xue Y; Behravan G; Jonsson BH; Lindskog S
Eur J Biochem; 1993 Feb; 211(3):821-7. PubMed ID: 8436138
[TBL] [Abstract][Full Text] [Related]
20. X-ray crystallographic studies of alanine-65 variants of carbonic anhydrase II reveal the structural basis of compromised proton transfer in catalysis.
Scolnick LR; Christianson DW
Biochemistry; 1996 Dec; 35(51):16429-34. PubMed ID: 8987974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]